Cutis laxa is a rare connective tissue disorder in which the skin loses its elasticity, becoming loose, saggy, and wrinkled. It can give even a young child or infant the appearance of being much older. Only about 200 cases have been reported in the medical literature worldwide. The condition can be inherited (present from birth or early childhood) or acquired later in life, and its severity ranges from a primarily cosmetic concern to a life-threatening illness depending on the type.
What Causes the Skin to Lose Elasticity
The core problem in cutis laxa is damage to or deficiency of elastic fibers in the skin and, in many cases, throughout the body’s internal organs. Elastic fibers are the stretchy components in connective tissue that let skin snap back into place after being pulled. In cutis laxa, these fibers are sparse, fragmented, or structurally abnormal. Importantly, the collagen network in the skin (which provides strength rather than stretch) is typically normal. This is a key distinction from other connective tissue disorders.
In inherited forms, gene mutations disrupt the proteins needed to build or maintain elastic fibers. In acquired forms, environmental exposures or inflammatory processes destroy elastic fibers that were previously healthy.
Inherited Forms and How They Differ
Inherited cutis laxa is grouped by its pattern of genetic transmission: autosomal dominant, autosomal recessive, or X-linked. These aren’t just genetic labels; each form has a meaningfully different outlook.
Autosomal Dominant Cutis Laxa
This is generally the mildest inherited form. It results from mutations in the elastin gene (ELN) or the fibulin-5 gene (FBLN5). Skin changes tend to appear later, sometimes not until adulthood, and internal organ involvement is either absent or mild. Most people with this form have a normal life expectancy. That said, it is no longer considered a purely cosmetic condition. Some individuals develop aortic aneurysms that require surgical repair, and severe lung disease (emphysema) has been reported. Other possible complications include hernias and organ prolapse, but systemic problems remain rare overall.
Autosomal Recessive Cutis Laxa
The autosomal recessive forms tend to be more severe and appear earlier in life. They are divided into two main types:
- Type 1 is likely the most serious form of cutis laxa. Skin involvement begins in infancy, and the condition frequently comes with restricted growth before birth, distinctive facial features, and skeletal abnormalities of the spine and chest. The greatest danger comes from the lungs: early-onset emphysema and collapsed lung (pneumothorax) can be fatal. Blood vessels may become abnormally twisted or widened, and hernias affecting the digestive and urinary tracts are common. Type 1 is linked to mutations in the gene for fibulin-5 (FBLN5) or a related protein called EFEMP2, which plays a role in keeping arteries structurally sound.
- Type 2 is generally less severe. The loose skin often spares the face but affects the hands and feet. Children with this form may have delayed growth, intellectual disability, loose joints, and hip dislocations. It is associated with mutations in the gene for lysyl oxidase, an enzyme that helps cross-link elastic fibers during their assembly.
X-Linked Cutis Laxa
This form, also known as occipital horn syndrome, is caused by mutations that disrupt copper transport in the body. Copper is essential for the enzymes that build elastic fibers, so when it can’t reach the right tissues, elastic fiber production suffers. Beyond loose skin, affected individuals (almost exclusively males) may develop wedge-shaped calcium deposits at the base of the skull, coarse hair, loose joints, and abnormalities of the blood vessels and urinary tract. Cognitive ability tends to be below average. Despite the range of features, this form carries a relatively favorable prognosis compared to severe autosomal recessive types.
Acquired Cutis Laxa
Not all cutis laxa is genetic. Some people develop it later in life after their elastic fibers are damaged by an outside trigger. The skin changes can appear gradually or follow an episode of inflammation, such as a rash or allergic reaction.
Several medications have been linked to acquired cutis laxa, including penicillin-type antibiotics, the tuberculosis drug isoniazid, penicillamine (used for conditions like Wilson disease), and certain antidepressants in the SSRI class. More unusual triggers have been reported as well, including hormonal intrauterine devices. Some cases develop alongside other medical conditions: a type of blood vessel inflammation called leukocytoclastic vasculitis and blood cancers like multiple myeloma have both been associated with acquired cutis laxa. In some patients, no clear trigger is ever identified.
How It Affects Organs Beyond the Skin
Because elastic fibers exist throughout the body, cutis laxa is not just a skin condition. The organs most commonly affected are the lungs, blood vessels, and digestive tract, though the pattern depends heavily on the specific type.
Lung problems are among the most concerning. Emphysema, where the tiny air sacs in the lungs lose their elasticity and break down, can appear surprisingly early in life in severe forms. This leads to progressive difficulty breathing. Bronchiectasis, a condition where the airways become permanently widened and prone to infection, is another possibility.
Vascular complications include twisted or widened arteries, narrowing of the pulmonary artery (which carries blood to the lungs), and, in some cases, aortic aneurysms or rupture. Hernias are common across multiple types because the weakened connective tissue cannot hold organs in their proper position. Bladder and urinary tract pouches (diverticula) can also develop. In the more severe recessive forms, developmental delays, intellectual disability, and seizures add a neurological dimension to the disease.
Diagnosis
The loose, sagging skin itself is the most obvious clue, but confirming cutis laxa and identifying its type requires additional testing. A skin biopsy examined under a microscope typically reveals the hallmark finding: sparse, fragmented elastic fibers with reduced density. Under electron microscopy, the elastic fibers in severe forms have a characteristic “moth-eaten” appearance, with abnormal branching and loosely scattered microfibrils surrounding deficient elastin cores.
Genetic testing is the definitive step for inherited forms. Identifying the specific gene mutation (in ELN, FBLN5, EFEMP2, or others) confirms the diagnosis and, critically, tells families which type they are dealing with. This matters because the prognosis and the organs that need monitoring vary so much between subtypes. For acquired cases, the diagnosis is clinical, supported by biopsy findings and the absence of a family history.
How Cutis Laxa Differs From Similar Conditions
Cutis laxa is sometimes confused with Ehlers-Danlos syndrome (EDS), another group of connective tissue disorders. The key difference is in what the skin does. In cutis laxa, the skin hangs loosely and does not snap back when pulled. In most types of EDS, the skin is hyperelastic, meaning it stretches far but then returns to its normal position. EDS also tends to cause fragile skin that tears and bruises easily, which is not a primary feature of cutis laxa. Interestingly, the X-linked form of cutis laxa was once classified as Ehlers-Danlos syndrome type IX before being reclassified, reflecting some genuine overlap between the conditions.
Treatment and Management
There is no cure for cutis laxa, and no treatment can restore the elastic fibers once they are lost or malformed. Management focuses on addressing the cosmetic impact and monitoring for internal complications.
Plastic surgery can improve the appearance of severely sagging skin, particularly on the face. However, because the underlying elastic fiber defect remains, the skin may gradually loosen again over time, and repeat procedures are sometimes needed.
The more important side of management is surveillance for organ complications. People with forms that carry vascular risk need regular monitoring of their heart and blood vessels, particularly the aorta. Lung function testing helps catch emphysema early. For children with severe recessive types, developmental support and physical therapy play a role in managing growth delays and joint instability. In acquired cutis laxa, identifying and removing the trigger (such as a medication) may help prevent further progression, though it generally does not reverse skin changes that have already occurred.
Outlook by Type
Prognosis varies enormously. People with autosomal dominant cutis laxa typically live a normal lifespan, with their main burden being the cosmetic effects and occasional need for surgery. The X-linked form also carries a relatively favorable outlook. Autosomal recessive type 2 causes significant challenges, including developmental delays and orthopedic problems, but is not usually life-threatening in itself.
Autosomal recessive type 1 is the most dangerous form. Fatal lung complications, particularly emphysema and pneumothorax, can occur in infancy or early childhood. Vascular abnormalities add further risk. For acquired cutis laxa, the outlook depends largely on whether internal organs are involved and whether the underlying trigger can be addressed.